Email Updates

You are here

AVAC's Blog: P-Values

  • Even close readers of the Weekly NewsDigest may be surprised to know that we are closing in on 18 years of weekly updates. Much has changed over these years – the HIV prevention news itself, the media world, and the technologies that help us compile and edit each issue. But there has always been one constant – the remarkable Polly Harrison!

    November 3, 2017
    General
    AVAC
  • In this second webinar in a series with Dr. Carl Dieffenbach, the Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases, we discussed the future of investments in the NIH HIV clinical trial research networks in the US and internationally.

    October 27, 2017
    General
    AVAC
  • In this webinar, colleagues from the Treatment Action Group (TAG), along with advocates, researchers and GPP practitioners, discussed the recommendations from the TAG's recently released white paper, HIV Research in the Era of PrEP: The Implications of TDF/FTC for Biomedical Prevention Trials.

    October 26, 2017
    AVAC
  • “You [advocates] push us as hard as you can. It’s your job, and you’re always mad,” said Carl Dieffenbach, Director of NIH’s Division of AIDS (DAIDS), who oversees a global HIV/AIDS research portfolio of more than US$1 billion. “And we’re always failing but in the end, there’s success. Keep pushing.”

    October 17, 2017
    Cindra Feuer
  • Please join AVAC and partners for two upcoming webinars on Thursday, October 26 and Friday, October 27. Thursday’s webinar is in partnership with the Treatment Action Group (TAG) and offers a chance to discuss the role of PrEP in HIV prevention trials. Friday’s webinar is with Dr. Carl Dieffenbach and provides an additional opportunity to talk about the focus and priorities for the NIH-funded HIV clinical trial networks.

    October 16, 2017
  • AVAC is testing a new way to bring you information and updates! Today we are introducing a podcast, Px Pulse, where advocates, researchers, policy makers and community stakeholders can hear from each other about HIV prevention research.

    October 12, 2017
  • AVAC is pleased to announce a call for applications for participation in its inaugural PxROAR Transgender program, specifically for transgender and gender non-conforming HIV prevention advocates in Eastern and Southern Africa.

    September 28, 2017
    General
    AVAC
  • This blog post first appeared on Positively Aware. It represents a report taken from a session presentation summary at this year’s US Conference on AIDS (USCA), a community-based event which was held in September in Washington, DC.

    September 28, 2017
    Positively Aware
  • In this audio interview, Slim Abdool Karim, co-principal investigator of the landmark CAPRISA 004 study, talks about why designing trials with oral PrEP is a must—scientifically and ethically.

    September 22, 2017
    AVAC
  • Check out the latest issue of Px Wire for a deep dive into the data that suggest men who have sex with men may be protected by oral PrEP, even if they don’t dose every day—and for the reasons why these data do not apply to women. You’ll also find out why messages about global AIDS are on our mind—and what we’d change about the current global conversation.

    September 14, 2017
    AVAC

Pages